Table of Contents
Globally, enzymes used in the manufacture of food and beverages will remain the largest market by value, with advances driven by increasing consumption of products containing enzymes in developing regions. Almost all industrial markets will experience healthy growth, with the exception of biofuels. Specialty markets will experience stronger growth, driven by changes in healthcare and the pharmaceutical industry. While the demand for enzymes used in research and biotechnology and diagnostics are forecast to register strong gains, the fastest growth will be seen for biocatalysts, particularly those utilized in the production of pharmaceuticals.
Producers face intense competition
As presented in the study World Enzymes, a new study from The Freedonia Group, developed countries have mature industrial markets with high levels of competition among enzyme manufacturers. In order to maintain and expand market share, manufacturers must continually improve their enzymes to offer efficient performance at lower temperatures or under more extreme pH conditions, lower costs through reduced energy and water usage, or higher quality end products and larger amounts of marketable co-products. This continued introduction of new enzyme formulations will fuel moderate growth in mature markets like food and beverages, cleaning products, and textiles and leather. Heightened interest in more niche applications, such as enzymatic production of protein hydrolysates for flavoring or protein supplementation, will also support growth in developed countries.
Rising healthcare costs to drive enzyme growth
Freedonia projects that specialty enzyme markets are expanding at a strong pace globally. Rising healthcare costs have led to the adoption of “personalized” medicine -- healthcare tailored to the individual based on their clinical profile, genetic background, and personal preferences -- by many providers. This approach to medicine requires the increased use of diagnostic testing as well as genomic sequencing, helping to drive strong demand for diagnostic enzymes. In developing countries, the number of diagnostic tests performed will increase as the number of insured individuals rises, further supporting growth in demand for the enzymes used in diagnostic testing. The competitive nature of the pharmaceutical industry will also lead to strong growth in specialty enzyme demand. Pharmaceutical companies will invest more in the development of biological pharmaceuticals, which will fuel demand for enzymes used in research and biotechnology. In addition, pharmaceutical companies will increasingly utilize biocatalysts to reduce the cost of pharmaceutical manufacturing and make non-generic drugs more cost-competitive.
World Enzymes presents historical data (2005, 2010 and 2015) plus forecasts (2020 and 2025) for supply and demand, as well as demand by type and market, in 6 regions and 15 countries. This study also considers key market environment factors, evaluates company market share and profiles 20 global competitors.
Freedonia's market research studies provide timely access to reliable, unbiased analysis from which to benchmark performance and answer critical questions: Is your business growing faster or slower than the overall market? Is your organization gaining or losing market share? Which products and markets are the most desirable to explore for expansion? Are there industry trends or competitor activities that present a threat or opportunity to your business?
Studies offer a great ROI and can help business leaders make informed, analytically driven decisions. When considering the time, effort, and expertise that goes into it, our off-the-shelf research saves our clients time and money.
Get Industry Insights. Simply.
Talk to Ahmad
+1 718 618 4302
The molecular biology enzymes and kits & reagents market is projected to reach USD 12.69 billion by 2021 from USD 5.77 billion in 2016, growing at a CAGR of 17.1% during the forecast period of 2016 to ...
The growing demand for processed foods and increasing health consciousness in the people is driving the food & beverages industry which inturn is driving the food enzymes market. Food enzymes are a majo ...
The North American industrial enzymes market was valued at USD XX.XX million in 2016 and is projected to reach USD XX.XX million by 2021 at a CAGR of XX.XX% during the forecast period from 2016 to 2021. ...